Company C21 Investments Inc Toronto S.E.
Equities
CWQ
CA23129E2069
Pharmaceuticals
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cannabis
100.0
%
| 41 | 100.0 % | 38 | 100.0 % | -8.54% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 41 | 100.0 % | 38 | 100.0 % | -8.54% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sonny Newman
CEO | Chief Executive Officer | - | 19-07-07 |
Michael Kidd
DFI | Director of Finance/CFO | - | 18-07-25 |
Aron Swan
COO | Chief Operating Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Macdonald
CHM | Chairman | - | 18-06-17 |
Leonard Werden
BRD | Director/Board Member | - | 17-07-24 |
Michael Kidd
DFI | Director of Finance/CFO | - | 18-07-25 |
Todd Harrison
BRD | Director/Board Member | - | 21-02-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 120,047,814 | 97,526,491 ( 81.24 %) | 0 | 81.24 % |
Company contact information
![address C21 Investments Inc(CWQ)](https://cdn.zonebourse.com/static/address/1409661.png)
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+9.94% | 4.81B | |
-32.21% | 3.6B | |
-1.43% | 3.09B | |
-25.09% | 2.62B | |
-11.46% | 2.27B | |
+36.65% | 1.82B | |
+37.15% | 1.41B | |
-16.01% | 1.38B | |
+40.95% | 1.37B |